Background. Acute kidney injury (AKI) is a common contributor to morbidity and mortality in newborns, with prevalences varying by population and hospital. A study of AKI in newborns in tertiary care centers in Thailand, a developing country with limited resources, has not been conducted yet. Methods. The aim of this study was to determine the prevalence of AKI in newborns in a tertiary care hospital in southern Thailand and to investigate the etiology, mortality and risk factors of mortality. The records of patients aged <30 days with high serum creatinine, admitted from 1984 to 2007, were retrospectively reviewed. Results. Eighty-eight boys and 51 girls were enrolled; 61.4% were premature and 56.5% had a birth weight <2500 g. The prevalence of newborn AKI increased from 0.9 to 6.3% during the 24-year study period. Thirty-nine and 65% had renal failure within 2 and 7 days post-birth, respectively. Sepsis was the most common cause of AKI (30.9%) followed by hypovolemia (18.7%), kidney, ureter and bladder (KUB) anomalies (12.2%), congestive heart failure (12.2%) and birth asphyxia (11.5%). Indomethacin caused AKI in 24.4% with gestational age <32 weeks. Sepsisinduced AKI had the highest mortality rate (65.1%) with an overall mortality rate of 38.8% and nearly 14 times the risk of death compared to hypovolemia-induced AKI.
Introduction
Acute kidney injury (AKI), a decrease in kidney function, causes retention of waste products and water retention. An abnormal rise of serum creatinine levels will confirm the diagnosis. Diagnosing AKI in newborns is more difficult than in other age groups due to the difficulty of clinical observation. In addition, the assessment of whether serum creatinine levels are rising in the neonatal period in the first few days of life is influenced by maternal serum creatinine [1] .
The incidence of AKI is age-dependent; newborns have the highest incidence followed by adults and children [1] . The incidence of AKI in newborns varies, depending on factors such as gestational age, birth weight, number and severity of complications and the facilities of the neonatal intensive care unit (NICU).
In tertiary care centers where there are advanced services, the number of referred cases is high; referred cases are normally more severe cases, and this increased number of more severe patients results in a higher prevalence of AKI in such centers. AKI increases the morbidity and mortality in all patients. In countries with limited resources, prevalence and outcomes may differ from more developed countries. Our institute serves as a referral medical center for the 14 provinces in southern Thailand.
There have been few studies on the impact of AKI in newborns. However, it is an important topic, as AKI in the neonatal period has been reported as one risk factor of developing chronic kidney disease (CKD) and hypertension, which can lead to the necessity of life-long monitoring and ongoing evaluation [1] [2] [3] .
Objective
The objective of this study was to evaluate the prevalence, mortality and independent risk factors of mortality in newborns with AKI from one tertiary care center in southern Thailand.
Materials and methods
We reviewed the medical records of children aged 0-30 days who had a diagnosis of AKI and attended the Pediatric Department of Prince of Songkla University Hospital in southern Thailand from 1984 to 2007. Variables recorded included date of birth, date of diagnosis of AKI, birth weight, gestational age, gender, primary disease causing AKI and maximum serum creatinine level measured during the first 30 days of life and mortality.
AKI was defined by a serum creatinine level !2mg/dL or a maximum serum creatinine level twice any previous level measured during the first 30 days of life [4] .
The etiologies of renal failure were determined by the major condition; for patients with multiple conditions contributing to renal failure, the most dominant one was determined according to clinical judgment.
The patients were divided into four age groups: 0-2, 3-7, 8-14 and 15-30 days. Years of diagnosis were divided into three time periods, 1984-95, 1996-2001 and 2002-07, consisting of 12, 6 and 6 years, respectively. These cut-points for age and diagnosis period were created in order to ensure roughly equal numbers of cases in each age group and period.
Descriptive statistics are shown as means and SD. Logistic regression was used to estimate risk factors for mortality adjusted for potential confounders. Risks for individual factors are shown as adjusted odds ratios and 95% confidence intervals (CI). P-values <0.05 were considered significant. The final model included all variables even if they were not significant. Statistical analysis was performed using R software version 2.10.1 [5] .
Results
In our 24-year study period, 139 newborns (88 boys, 51 girls) were found to have abnormally high serum creatinine for their age. One hundred and thirty-three newborns were subsequently diagnosed as having AKI, with six having CKD. In the three time periods, 1984-95, 1996-2001 and 2002-07, the prevalences of renal failure in neonates were 17, 45 and 77 cases, respectively, and the percentages of renal failure in all admitted newborns in each era were 0.9, 4.5 and 6.3, respectively.
One hundred and twenty-seven newborns had gestational age recorded with mean AE SD 35.0 AE 4.8 weeks, median 36 and range 25-42. The prevalence of premature birth was 61.4% (78/127). One hundred and thirty-one newborns had birth weight recorded with mean AE SD 2253 AE 933 g, median 2300 and range 550-4100; 56.5% (74/131) weighed <2500 g.
The mean age at diagnosis of AKI was 7.1 AE 7.5 days with a median of 4 and range 0-29 days. The mean maximum serum creatinine was 2.3 AE 1.5 mg/dL with a median of 1.9 mg/dL and a range of 1.0-10.4 mg/dL. Table 1 shows the etiologies of renal failure in the four age groups. Sepsis was the most common etiology (30.9%) with a mortality rate of 65.1%. Sepsis-induced AKI occurred in equal proportions among the age groups. Thirty-nine and 65% of the newborns with AKI in our study had renal failure within 2 and 7 days after birth, respectively. The major etiologies of AKI in newborns aged <2 days in our study were hypovolemia, sepsis and birth asphyxia.
The twenty-six cases of AKI (18.7%) caused by hypovolemia, the second most common cause of AKI in our study, were mostly due to congenital gut obstruction and gastroschisis. Most of these cases were referred to our institution for surgery. Four of these patients died [three developed sepsis and one due to primary pulmonary hypertension (PPHN)].
Eighteen patients had a congenital kidney, ureter and bladder (KUB) anomaly, of whom 12 developed AKI. Nine cases had obstructive uropathy [four had a posterior urethral valve (PUV) obstruction, two a ureteropelvic junction (UPJ) obstruction only (one died), one had a cystic lesion in the bladder, one exstrophy bladder and one anorectal malformation with single kidney and UPJ obstruction]. There were three non-obstructive uropathy cases; all had cystic kidney disease (two died). Six patients were eventually diagnosed with CKD. Of these, one had cystic kidney disease, two dysplastic kidney, two primary vesicoureteral reflux (VUR) with dysplastic kidney and one PUV obstruction with dysplastic kidney. One VUR with dysplastic kidney had sepsis and developed AKI on top of CKD (his final etiology was recorded as sepsis).
Other causes included two with respiratory distress syndrome and one each with PPHN and post-cardiac arrest. One patient with sepsis had peritoneal dialysis performed, but subsequently died. The overall total mortality rate was 38.8%. Table 2 shows the results of fitting a logistic regression model to the data. Disease etiology was the only independent risk factor for mortality in AKI newborns. Patients with sepsis-induced AKI had nearly 14 times the risk of death compared to patients with hypovolemia-induced AKI, although the 95% CI was wide (3-64). Gestational age, birth weight, gender, maximum serum creatinine level and time period were not significant risk factors.
Discussion
AKI in newborns was found in 6.4% of all admitted newborns in our tertiary care hospital, with sepsis being the most common cause of AKI. This group also had the highest mortality rate. The prevalence of renal failure in newborns in our institute has increased over the years, as reported in our previous study of AKI in children [6] . This increase reflects the greater variety of modern treatments that can be given to save the lives of neonates born with critical conditions, particularly heart surgery, and also improvements to the regional transportation system have increased the number of newborns with complicated conditions referred to a tertiary care institution such as ours. The prevalence of AKI in newborns in one NICU in Turkey was reported as 3.4%, of which 31.1% were premature, which is half the rate found in our study [7] .
The diagnosis of neonatal AKI using a definition of decreasing urine output (<1 mL/kg/h) [8] is difficult since urine output is usually unobserved; additionally, some patients have non-oliguric renal failure. For neonates at high risk of AKI, a serum creatinine measurement should be taken in order to obtain a more definitive diagnosis. AKI in this study was determined using a creatinine level of !2 mg/dL, unlike some other studies which have used 1.5 mg/ dL, because high creatinine levels in the newborn can represent mother's creatinine levels soon after birth. To prevent the possible exclusion of neonates with AKI from using our first criterion of serum creatinine !2.0 mg/dL, we also used the 'doubling' criterion, that is, if a child's creatinine increased by a factor of 2 between any two measurements, regardless of the value of either measurement, then this child was included in our study. This second criterion would pick up any neonatal AKI patients that were missed with the first criterion.
In our institute, an earlier study found sepsis was the most common cause of AKI in newborns as well as in Table 2 . children aged >30 days [6] . A study from India in 200 newborns with sepsis showed that 26% developed AKI and the mortality rate in those who had AKI was much higher than in those who did not (70 versus 25%, P < 0.001) [9] . In our study, the mortality rate for newborns with sepsis-caused AKI was comparable (65%). Birth asphyxia was found to be the fifth most common cause of AKI in our study (16/139) . Other studies have found asphyxia to be the most common cause of AKI (40-56%) [7, 10, 11] .
Mak [3] reported that nephrotoxicity caused 16% of AKI cases in children. Newborns suffering to nephrotoxicity are commonly treated with aminoglycoside for sepsis, indomethacin for patent ductus arteriosus (PDA) closure and angiotensin-converting enzyme inhibitor (ACEI) for congestive heart failure. All of these conditions and medications compromise kidney function, therefore close monitoring of kidney function is essential in infants undergoing these treatments. Indomethacin is reported to be a common toxin causing AKI in newborns. In one study, 24% of 54 newborns with gestational age <30 weeks and receiving indomethacin for PDA closure developed AKI [12] , a prevalence similar to our study (10/41) with gestational age <32 weeks. Three newborns in our study had indomethacin-induced AKI, and although the AKI resolved, they died from other causes (two from sepsis and one due to chronic lung disease at 5 months).
ACEI-induced AKI is occasionally reported in newborns and may be either reversible or irreversible [13] [14] [15] . In our study, there was one case of ACEI-induced AKI. Although the AKI was resolved, the patient did not survive due to arrhythmia. ACEI therapy in newborns should be avoided if possible, and if necessary, it should be used with extreme caution with close monitoring of kidney function, starting with low doses and increasing the dosage gradually until efficacy is reached with the lowest possible dose [15] .
Congenital KUB anomaly is an important cause of AKI in newborns. The more important anomalies are some form of obstructive uropathy, such as PUV or UPJ obstruction, which are both surgically correctable conditions, and require urinary drainage to be resolved. AKI can be resolved after the obstruction has been corrected; any resulting kidney damage (dysplasia) is often not severe, except in rare cases. In our study, there were nine cases of obstructive uropathy and all had either urinary bladder catheterization, percutaneous nephrostomy or cystostomy performed.
Pre-natal ultrasound for detecting KUB anomalies is important because it can help to predict the possibility of AKI after birth, particularly if bilateral renal dysplasia or lower urinary tract obstruction is present or if there is urinary tract obstruction in a solitary kidney [8] . The pre-natal diagnosis of KUB anomalies with suspected kidney impairment is not common in Thailand since investigations, which would detect such anomalies, are only performed if an anomaly is suspected. Almost all patients who are diagnosed with KUB anomalies are diagnosed after further investigations are performed following urinary tract infection and even AKI diagnosis, both of which are direct consequences of KUB anomalies. Additionally, renal replacement therapy (RRT) is rarely available in developing countries where resources are limited [16] . In our institute, dialysis is re-served for AKI cases and CKD cases with potential renal transplantation.
AKI is not normally a direct cause of death [17] . The cause of death for patients diagnosed with AKI may not be the same as the cause of AKI. The mortality rate depends on other associated conditions, e.g. other organ failure, particularly cardiac failure, birth asphyxia and serious infection. The mortality rate in a Turkish study was 22.4% [7] . In 248 children with AKI from one tertiary care center in the USA, 62 were newborns. In this group, congenital heart disease was the most common cause (17/62) and 28 died [18] . Another study on 149 children with AKI from Costa Rica found that the rate of AKI in newborns was 44% with a mortality rate of 42%. The mortality rates in premature and full-term newborns were not significantly different (40 versus 45%), which was comparable to our study's combined rate of 38.8% [19] .
The outcome of AKI in critically ill neonates is poor [1] ; however, independent risk factors have not been definitively established. One study found that an increase of 1 mg/dL of serum creatinine in very low birth weight (VLBW) infants almost doubled the risk of death [20] . The same study found that AKI was the only independent risk factor of death in VLBW infants.
The causes of AKI and death are quite difficult to determine conclusively since some conditions and their treatments may both lead to AKI, such as sepsis with aminoglycoside therapy and congestive heart failure with indomethacin treatment for PDA, thus a clear diagnosis in a rapidly developing and confusing situation is often impossible. AKI can result from a combination of factors. In our study, for newborns with a complex of diseases, we chose the major contributing condition as the final cause of AKI.
There is no specific treatment for the majority of AKI cases in pre-and intrinsic renal failure. Adjunctive/symptomatic treatment and treatment aimed at the cause of the renal failure (such as diuretic and digitalis for congestive heart failure) are essential; however, RRT, a major supportive treatment, is required in less than one-fourth of all cases [6, 7] . If given, peritoneal dialysis is the option of choice for newborns since it is the easiest modality of RRT [2, 8, 16] .
Pre-renal failure is the most common type of AKI in neonates, and since pre-renal failure is fully curable if treated promptly, prompt diagnosis and appropriate management provide an excellent outcome [8, 16] .
Conclusion
AKI, a serious condition in newborns, was commonly associated with high morbidity and mortality in this 24-year retrospective study from a tertiary referral center in southern Thailand, a developing country with limited resources. The prevalence of AKI was~6% of admitted newborns, and more than half developed AKI within the first 7 days of life. Multiple factors caused the AKI, the most important and common one being sepsis. The overall mortality was 39% and the highest mortality occurred in sepsis-induced AKI. Etiologic disease of AKI was an independent risk factor of mortality, while gestational age, birth weight, gender, age at diagnosis of AKI and maximum serum creatinine level were not significantly implicated.
